Vaxcyte (PCVX) Research & Development (2019 - 2026)
Vaxcyte (PCVX) reported Research & Development of $267.85 million for Q2 2026, up 37.9% from $194.18 million a year earlier but down 14.4% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Research & Development (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vaxcyte's Research & Development came in at $1.03 billion, up 74.2% year-over-year; for FY2025, it came in at $794.31 million, up 66.6% from FY2024.
- Research & Development has increased for seven consecutive years, with a five-year compound annual growth rate of 60.9% (FY2020 to FY2025).
- By year, Research & Development came in at $476.64 million in FY2024 (+43.4%), $332.34 million in FY2023 (+96.1%), $169.45 million in FY2022 (+116.1%) and $78.41 million in FY2021 (+6.6%).
- Five-year quarterly Research & Development spans a low of $20.43 million in Q3 2021 and a high of $312.78 million in Q1 2026.
- Year over year, Research & Development has now increased in each of the last 20 quarters, with growth averaging 57.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Research & Development ran from 20.0% in Q3 2024 to 133.4% in Q3 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at $312.78 million (Q1 2026), $242.06 million (Q4 2025) and $209.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Vaxcyte | 8.44 Bn | 8.44 Bn | - | 267.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 267.85 Mn |
| Mar 31, 2026 | 312.78 Mn |
| Dec 31, 2025 | 242.06 Mn |
| Sep 30, 2025 | 209.93 Mn |
| Jun 30, 2025 | 194.18 Mn |
| Mar 31, 2025 | 148.13 Mn |
| Dec 31, 2024 | 133.61 Mn |
| Sep 30, 2024 | 116.94 Mn |
| Jun 30, 2024 | 131.51 Mn |
| Mar 31, 2024 | 94.59 Mn |
| Dec 31, 2023 | 104.15 Mn |
| Sep 30, 2023 | 97.42 Mn |
| Jun 30, 2023 | 72.69 Mn |
| Mar 31, 2023 | 58.08 Mn |
| Dec 31, 2022 | 51.63 Mn |
| Sep 30, 2022 | 47.68 Mn |
| Jun 30, 2022 | 38.47 Mn |
| Mar 31, 2022 | 31.68 Mn |
| Dec 31, 2021 | 23.07 Mn |
| Sep 30, 2021 | 20.43 Mn |
API Access
Vaxcyte Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();